|
WO2021062227A2
|
|
Compositions and methods for treatment of liquid cancers
|
|
WO2021050571A1
|
|
Novel nucleobase editors and methods of using same
|
|
WO2021050512A1
|
|
Novel crispr enzymes, methods, systems and uses thereof
|
|
WO2021041885A2
|
|
Compositions and methods for editing a mutation to permit transcription or expression
|
|
WO2021041945A2
|
|
Compositions and methods for non-toxic conditioning
|
|
WO2020236936A1
|
|
Methods of editing a single nucleotide polymorphism using programmable base editor systems
|
|
WO2020231863A1
|
|
Compositions and methods for treating hepatitis b
|
|
WO2020168122A1
|
|
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
WO2020168051A1
|
|
Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
WO2020168133A1
|
|
Compositions and methods for treating hemoglobinopathies
|
|
WO2020168135A1
|
|
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
WO2020168075A1
|
|
Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
WO2020168132A1
|
|
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
|
|
WO2020168088A1
|
|
Compositions and methods for treating glycogen storage disease type 1a
|
|
WO2020163218A1
|
|
Systems and methods for implemented mixed reality in laboratory automation
|
|
WO2020160517A1
|
|
Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence
|
|
WO2020160514A1
|
|
Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors
|
|
WO2020150534A2
|
|
Modified immune cells having enhanced anti-neoplasia activity and immunosuppression resistance
|
|
WO2020051562A2
|
|
Compositions and methods for improving base editing
|
|
CA3112011A1
|
|
Compositions and methods for delivering a nucleobase editing system
|
